Stock listing
NYSE American:CLDI Calidi Biotherapeutics, Inc. Stock
Home listing (NYSE American) of Calidi Biotherapeutics, Inc.
Follow Calidi Biotherapeutics, Inc. into a list and get an email when it puts out news.
Share price · AMEX:CLDI
$0.688 USD +0.016 (+2.4%)
Close on Oct 30, 2026
- Day range
- $0.650 – $0.688 USDOct 30, 2026
- Volume
- 48,393 sharesOct 30, 2026
- Market cap
- $2.53M USDAt the close on Oct 30, 2026 · price × 3.68M shares outstanding
- 52-week range
- $0.620 – $27.040 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $174,889 USDMedian day 50,200 shares · 1 day with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:CLDI · Home | $0.688 USD | +0.016 (+2.4%) | 48,393 | $0.667 | $0.688 | $0.650 | $0.672 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:CLDI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.688 | +0.016 | +2.4% | $0.667 | $0.688 | $0.650 | 48,393 | |
| $0.672 | -0.030 | -4.3% | $0.650 | $0.706 | $0.650 | 18,203 | |
| $0.702 | +0.042 | +6.3% | $0.700 | $0.719 | $0.664 | 27,526 | |
| $0.660 | +0.020 | +3.1% | $0.669 | $0.700 | $0.623 | 31,284 | |
| $0.640 | -0.005 | -0.8% | $0.650 | $0.650 | $0.630 | 41,419 | |
| $0.645 | -0.005 | -0.8% | $0.650 | $0.660 | $0.629 | 37,600 | |
| $0.650 | -0.118 | -15.4% | $0.770 | $0.770 | $0.620 | 201,100 | |
| $0.768 | -0.002 | -0.3% | $0.759 | $0.790 | $0.731 | 63,700 | |
| $0.770 | -0.013 | -1.7% | $0.750 | $0.779 | $0.750 | 26,900 | |
| $0.783 | -0.054 | -6.5% | $0.801 | $0.831 | $0.751 | 54,800 | |
| $0.837 | -0.033 | -3.8% | $0.890 | $0.890 | $0.790 | 35,100 | |
| $0.870 | -0.004 | -0.5% | $0.870 | $0.890 | $0.857 | 23,800 | |
| $0.874 | -0.026 | -2.9% | $0.900 | $0.920 | $0.820 | 52,800 | |
| $0.900 | -0.050 | -5.3% | $0.933 | $0.933 | $0.870 | 63,800 | |
| $0.950 | -0.080 | -7.8% | $0.998 | $0.998 | $0.937 | 52,600 | |
| $1.030 | -0.010 | -1.0% | $1.040 | $1.050 | $1.030 | 18,000 | |
| $1.040 | +0.030 | +3.0% | $1.020 | $1.041 | $1.000 | 18,200 | |
| $1.010 | -0.010 | -1.0% | $1.020 | $1.030 | $0.986 | 51,500 | |
| $1.020 | -0.030 | -2.9% | $1.060 | $1.070 | $1.000 | 71,700 | |
| $1.050 | -0.030 | -2.8% | $1.080 | $1.120 | $1.000 | 22,000 | |
| $1.080 | 0.000 | 0.0% | $1.090 | $1.090 | $1.050 | 38,600 | |
| $1.080 | +0.010 | +0.9% | $1.065 | $1.080 | $1.050 | 14,900 | |
| $1.070 | -0.010 | -0.9% | $1.080 | $1.095 | $1.050 | 48,900 | |
| $1.080 | +0.010 | +0.9% | $1.075 | $1.080 | $1.030 | 43,200 | |
| $1.070 | -0.060 | -5.3% | $1.100 | $1.130 | $1.050 | 154,500 | |
| $1.130 | -0.070 | -5.8% | $1.200 | $1.290 | $1.130 | 128,600 | |
| $1.200 | +0.110 | +10.1% | $1.150 | $1.250 | $1.100 | 587,800 | |
| $1.090 | -0.020 | -1.8% | $1.100 | $1.150 | $1.050 | 2,882,800 | |
| $1.110 | -0.002 | -0.2% | $1.111 | $1.150 | $1.110 | 37,100 | |
| $1.112 | +0.012 | +1.1% | $1.110 | $1.163 | $1.100 | 33,400 | |
| $1.100 | -0.170 | -13.4% | $1.280 | $1.280 | $1.100 | 30,600 | |
| $1.270 | +0.100 | +8.5% | $1.150 | $1.290 | $1.050 | 189,000 | |
| $1.170 | 0.000 | 0.0% | $1.220 | $1.230 | $1.160 | 32,400 | |
| $1.170 | -0.050 | -4.1% | $1.210 | $1.220 | $1.170 | 33,900 | |
| $1.220 | -0.020 | -1.6% | $1.270 | $1.270 | $1.210 | 17,500 | |
| $1.240 | -0.070 | -5.3% | $1.240 | $1.280 | $1.220 | 70,600 | |
| $1.310 | -0.050 | -3.7% | $1.310 | $1.340 | $1.300 | 32,400 | |
| $1.360 | +0.010 | +0.7% | $1.330 | $1.370 | $1.301 | 45,300 | |
| $1.350 | -0.035 | -2.5% | $1.380 | $1.400 | $1.250 | 30,000 | |
| $1.385 | +0.035 | +2.6% | $1.380 | $1.400 | $1.350 | 19,000 | |
| $1.350 | +0.010 | +0.7% | $1.330 | $1.380 | $1.320 | 23,600 | |
| $1.340 | +0.010 | +0.8% | $1.332 | $1.410 | $1.330 | 30,100 | |
| $1.330 | -0.010 | -0.7% | $1.330 | $1.360 | $1.280 | 48,500 | |
| $1.340 | +0.020 | +1.5% | $1.320 | $1.380 | $1.310 | 35,800 | |
| $1.320 | +0.020 | +1.5% | $1.320 | $1.370 | $1.280 | 51,800 | |
| $1.300 | -0.050 | -3.7% | $1.330 | $1.420 | $1.260 | 129,400 | |
| $1.350 | +0.040 | +3.1% | $1.310 | $1.370 | $1.310 | 38,800 | |
| $1.310 | -0.070 | -5.1% | $1.350 | $1.405 | $1.310 | 48,200 | |
| $1.380 | +0.040 | +3.0% | $1.340 | $1.380 | $1.260 | 62,200 | |
| $1.340 | 0.000 | 0.0% | $1.350 | $1.410 | $1.310 | 58,100 | |
| $1.340 | -0.040 | -2.9% | $1.350 | $1.390 | $1.270 | 79,600 | |
| $1.380 | +0.110 | +8.7% | $1.250 | $1.460 | $1.250 | 139,900 | |
| $1.270 | -0.090 | -6.6% | $1.320 | $1.340 | $1.250 | 135,800 | |
| $1.360 | -0.230 | -14.5% | $1.580 | $1.580 | $1.330 | 296,800 | |
| $1.590 | +0.050 | +3.2% | $1.500 | $1.630 | $1.500 | 155,800 | |
| $1.540 | -0.090 | -5.5% | $1.570 | $1.590 | $1.500 | 181,000 | |
| $1.630 | -0.010 | -0.6% | $1.630 | $1.636 | $1.570 | 113,300 | |
| $1.640 | +0.010 | +0.6% | $1.630 | $1.700 | $1.558 | 232,500 | |
| $1.630 | +0.010 | +0.6% | $1.630 | $1.700 | $1.605 | 163,600 | |
| $1.620 | -0.170 | -9.5% | $1.790 | $1.790 | $1.570 | 204,700 | |
| $1.790 | +0.030 | +1.7% | $1.750 | $1.879 | $1.730 | 254,000 | |
| $1.760 | -0.130 | -6.9% | $1.870 | $1.870 | $1.680 | 171,000 | |
| $1.890 | +0.210 | +12.5% | $1.630 | $1.910 | $1.629 | 275,500 | |
| $1.680 | +0.040 | +2.4% | $1.620 | $1.690 | $1.530 | 264,500 | |
| $1.640 | +0.152 | +10.2% | $1.930 | $1.930 | $1.530 | 464,500 | |
| $1.488 | 0.000 | 0.0% | $1.488 | $1.488 | $1.488 | 0 |
- Ticker
- NYSE American:CLDI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
Latest deck · April 2026
Investor Presentation (April 2026)
Investor deck · 13 slides
Latest news
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
Oct 27, 2026
Closed $0.66 (+3.1%) on Oct 27, 2026
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
Oct 19, 2026
Closed $0.783 (-6.5%) on Oct 19, 2026
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
Sep 17, 2026
Closed $1.27 (+8.5%) on Sep 17, 2026
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 13, 2026
Closed $1.59 (+3.2%) on Aug 14, 2026
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
Jul 22, 2026
Closed $1.70 (+6.0%) on Jul 22, 2026
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
Jul 20, 2026
Closed $1.60 (-13.8%) on Jul 21, 2026
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
Jun 24, 2026
Closed $2.51 (+0.6%) on Jun 24, 2026
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Jun 23, 2026
Closed $2.50 (-2.5%) on Jun 23, 2026
Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
Jun 16, 2026
Closed $2.54 (-1.9%) on Jun 16, 2026
Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026
Jun 8, 2026
Closed $2.80 (+3.6%) on Jun 8, 2026
Financings
Registered direct offering of shares of common stock
Sep 17, 2026
Announced: about US$1.2M · US$1.17 a share
Use of proceeds: Working capital and general corporate purposes
Decks
Investor Presentation (April 2026)
Investor deck · 13 slides · April 2026
Investor Presentation (February 2026)
Investor deck · 23 slides · Feb 10, 2026
Investor Presentation (October 2025)
Investor deck · 22 slides · Oct 24, 2025
Investor Presentation (October 2025)
Investor deck · 22 slides · Oct 22, 2025
Calidi Biotherapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 55 in all · newest Oct 27, 2026 · oldest 2024
- Decks
- 18 decks · latest April 2026
Where Calidi Biotherapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:CLDI · Home listing · This page | NYSE American | United States | USD |
| BOATS:CLDI | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Calidi Biotherapeutics, Inc.